Antimicrobial Central Venous Catheter Perfect combination of Rifampin and Minocydine Expert of CRBSI inhibition To improve the anti-microbial effect of CVC, extend the implantation duration of catheters in human body. Lepu?s R&D specialists utilized the prolonged drug release technology of coating catheter and successfully developed antimicrobial CVC. Molecular level of Minocycline and Rifampicin is infiltrated on both internal and external wall of catheter and released gradually after implantation. Durable and reliable anti-bacterial effect guarantees successful prevention of CRBSI. Description of coating Rifampin (C43H58N4012) Minocydine (C23H27N307) Function Reduce the risk of infection Extend the implantation duration of catheters in human body
a:3:{i:0;a:2:{s:4:"name";s:12:"Application:";s:3:"val";s:10:"anesthesia";}i:1;a:2:{s:4:"name";s:17:"Area of the body:";s:3:"val";s:14:"central venous";}i:2;a:2:{s:4:"name";s:16:"Characteristics:";s:3:"val";s:13:"antimicrobial";}}
